Naratriptan HCl (GR-85548A; GR85548A; Amerge; Naramig), the hydrochloride salt of naratriptan, is a triptan class of selective 5-HT₁ receptor subtype agonist used for the treatment of migraine headaches. was created and distributed by GSK, and tablets containing 2.5 mg are available. Naratriptan functions as a selective agonist of the 5-HT1 receptor subtype as its mode of action. Naratriptan is used to treat acute migraine attacks as well as the symptoms of migraine, which include intense, throbbing headaches that can occasionally be accompanied by light or sound sensitivity and nausea.
Physicochemical Properties
| Molecular Formula | C17H26CLN3O2S | |
| Molecular Weight | 371.93 | |
| Exact Mass | 371.143 | |
| Elemental Analysis | C, 54.90; H, 7.05; Cl, 9.53; N, 11.30; O, 8.60; S, 8.62 | |
| CAS # | 143388-64-1 | |
| Related CAS # | Naratriptan; 121679-13-8; Naratriptan-d3 hydrochloride; 1190021-64-7 | |
| PubChem CID | 60875 | |
| Appearance | White to off-white solid powder | |
| Boiling Point | 541.3ºC at760mmHg | |
| Melting Point | 234-236ºC | |
| Flash Point | 281.2ºC | |
| Vapour Pressure | 8.81E-12mmHg at 25°C | |
| LogP | 4.28 | |
| Hydrogen Bond Donor Count | 3 | |
| Hydrogen Bond Acceptor Count | 4 | |
| Rotatable Bond Count | 5 | |
| Heavy Atom Count | 24 | |
| Complexity | 483 | |
| Defined Atom Stereocenter Count | 0 | |
| SMILES | Cl[H].S(C([H])([H])C([H])([H])C1C([H])=C([H])C2=C(C=1[H])C(=C([H])N2[H])C1([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H])(N([H])C([H])([H])[H])(=O)=O |
|
| InChi Key | AWEZYKMQFAUBTD-UHFFFAOYSA-N | |
| InChi Code | InChI=1S/C17H25N3O2S.ClH/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14;/h3-4,11-12,14,18-19H,5-10H2,1-2H3;1H | |
| Chemical Name | N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;hydrochloride | |
| Synonyms |
|
|
| HS Tariff Code | 2935.90.6000 | |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
|
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | 5-HT1 Receptor | ||
| ln Vitro |
|
||
| ln Vivo |
|
||
| Animal Protocol |
|
||
| References |
[1]. J Headache Pain.2011 Aug;12(4):399-403. |
||
| Additional Infomation |
Naratriptan Hydrochloride is the hydrochloride salt form of naratriptan, a sulfonamide with selective serotonin (5-HT) 1 receptor agonistic activity and anti-migraine property. Naratriptan hydrochloride binds selectively and with high affinity to the 5-HT1D and 5-HT1B receptor subtypes. Activation of these 5-HT1D/B receptors located on intracranial blood vessels leads to vasoconstriction and provides relief of migraine headaches. Naratriptan hydrochloride may also exerts its effect by stimulation of 5-HT1D/1B receptors on sensory nerve endings in the trigeminal system thereby decreasing the release of pro-inflammatory neuropeptides. See also: Naratriptan (has active moiety). |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: 6.67 mg/mL (17.93 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication (<60°C). Solubility in Formulation 2: 5%DMSO + 40%PEG300 + 5%Tween 80 + 50%ddH2O: 3.7mg/ml (9.95mM)  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6887 mL | 13.4434 mL | 26.8868 mL | |
| 5 mM | 0.5377 mL | 2.6887 mL | 5.3774 mL | |
| 10 mM | 0.2689 mL | 1.3443 mL | 2.6887 mL |